Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06202274 · ClinicalTrials.gov registry record · NA
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
A NA study of Acne and Wrinkle, sponsored by Candela Corporation.
- Active
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 3
- Study locations
NCT06202274 is a NA study of Acne and Wrinkle that is active but no longer recruiting, run by Candela Corporation. The registered enrollment target is 500 participants, above the 123-participant average among 26 other Acne trials with a reported enrollment target (307% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT06202274, a NA study of Acne and Wrinkle, is active but no longer recruiting, sponsored by Candela Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a non-randomized, multi-center, open-label, prospective clinical study evaluating the clinical treatment with Candela Medical Technology.
Conditions Studied
Interventions
- DEVICE Nordlys, Gentle, Picoway, Vbeam, Profound, Profound Matrix, eTwo, Exceed, CO2RE
Study Locations (3)
Florida
- Center for Morden Aesthetic Medicine - Jacksonville
Massachusetts
- Candela Institue for Excellence - Marlborough
Other
- Yokneam Candela Clinic - Yokneam Illit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-10-04 |
| Est. Completion | 2029-10-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06202274
The ClinicalTrials.gov registry entry for NCT06202274 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 123-participant average among 26 other Acne trials with a reported enrollment target (307% higher). The listed sponsor is Candela Corporation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Acne appearing as the primary indexed condition, and to 1 intervention - of which Nordlys, Gentle, Picoway, Vbeam, Profound, Profound Matrix, eTwo, Exceed, CO2RE is the first listed.
NCT06202274 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Massachusetts, Other.
Frequently Asked Questions
What is clinical trial NCT06202274 about?
NCT06202274 is a clinical study titled "Clinical Study to Evaluate the Safety and Efficacy of Candela Technology". This is a non-randomized, multi-center, open-label, prospective clinical study evaluating the clinical treatment with Candela Medical Technology.
What is the current status of trial NCT06202274?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2023-10-04. Estimated completion is 2029-10-04.
What conditions does trial NCT06202274 study?
This clinical trial studies the following conditions: Acne, Wrinkle, Scars, Tattoo Removal, Skin Conditions.
What interventions are being tested in trial NCT06202274?
The interventions under investigation include: Nordlys, Gentle, Picoway, Vbeam, Profound, Profound Matrix, eTwo, Exceed, CO2RE (DEVICE).
Who is sponsoring clinical trial NCT06202274?
This trial is sponsored by Candela Corporation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06202274 being conducted?
This trial has 3 study locations across Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production
RECRUITING · NA
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
RECRUITING · NA
-
The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation
COMPLETED · NA
-
An Exploratory Investigation of a Male Focused Skincare Supplement
COMPLETED · NA
-
An Exploratory Investigation of a Novel Skincare Regimen
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.